[Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects].
Yamanaka
Hisashi
H
Institute of Rheumatology, Tokyo Women's Medical University.
D000493:Allopurinol / Q000008:administration & dosage / Q000009:adverse effects; D001161:Arteriosclerosis / Q000209:etiology; D001553:Benzbromarone / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006073:Gout / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy*; D007674:Kidney Diseases / Q000209:etiology; D011339:Probenecid / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D012306:Risk; D014528:Uricosuric Agents / Q000008:administration & dosage / Q000009:adverse effects; D014545:Urinary Calculi; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D014528:Uricosuric Agents; D001553:Benzbromarone; D000493:Allopurinol; D014969:Xanthine Oxidase; D011339:Probenecid